APP Pharmacology Series presented by MGH and BWH APP Education Committees 2022-2023: Archived


This activity provides on-demand archived lectures from the APP Pharmacology Series presented by MGH and BWH APP Education Committees 2022-2023. The educational series is designed to provide clinical content that is relevant to multiple disciplines throughout the Mass General Brigham organization. The lectures are designed to provide concise and accurate information that clinicians can use to provide evidence-based care. The lectures have been designed based on feedback from community members.

By having presenters that are credentialed PAs, NPs, MDs, and pharmacists, this will truly serve to be an interprofessional series that will highlight how these professions work closely with one another to provide best patient care and best patient outcomes.

Course Directors:
Erin Schroeder, NP & Ariel Nowicki, PA-C

For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at

You may print individual certificates throughout the year; your cumulative list of completed activities is accessible on your transcript.

Target Audience

This activity is intended for all APPs, MDs, and Pharmacists within Mass General Brigham 

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Apply evidence-based pain management strategies to reduce unnecessary opioid prescribing and in turn reduce patient harm.
  2. Identify the most up-to-date and evidence-based treatments for diabetes
  3. Identify and manage potentially life-threatening side effects of immunotherapy by working with Severe Immunotherapy Complications team of MDs and NPs to reduce harm and improve patient outcomes   
  4. Review and safely reduce medication lists for elderly patients who are at risk for polypharmacy and the possible complications that can accompany polypharmacy, specifically sedation, falls, kidney and liver damage, as well as increased health care costs
  5. Apply up to date guidelines in safe prescribing of patients for conditions discussed in series (i.e., GI disorders, substance use disorder, etc.)
  6. Identify role of various professions (MD, NP, PA, Pharmacists) in safe prescribing of patients with conditions discussed (i.e, GI disorders, substance use disorder, etc.)

Additional Information

Provided by: 

Mass General Brigham

Course summary
Course opens: 
Course expires: 



July 26, 2022

Pain Management

Paul Arnstein, RN, PhD, FAAN

August 23, 2022

Diabetes Medications Update

Delaney Corcoran, Pharm.D
Gretchen Stern, Pharm.D., BCPS

September 27, 2022

Immunotherapy Toxicity & Management

Kerry Reynolds, MD
Nora Hathaway, CNP

October 25, 2022

Hypertension Management and Medication Considerations   

Dareen Kanaan, PharmD, MPH, BCCP

November 22, 2022

Considerations for Antipsychotic Use in Patient Care

Christine Kim, PharmD
Lydia Ware, PharmD, BCPS


Course Directors

Erin Schroeder, CNP
Nurse Practitioner, Gynecologic Oncology,
Massachusetts General Hospital

Ariel Nowicki, PA-C
Neurosurgery ICU Physician Assistant,
Brigham and Women's Hospital


Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Examples of such organizations include:

  • Advertising, marketing, or communication firms whose clients are ineligible companies
  • Bio-medical startups that have begun a governmental regulatory approval process
  • Compounding pharmacies that manufacture proprietary compounds
  • Device manufacturers or distributors
  • Diagnostic labs that sell proprietary products
  • Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
  • Manufacturers of health-related wearable products
  • Pharmaceutical companies or distributors
  • Pharmacy benefit managers
  • Reagent manufacturers or sellers

For more information:

Mass General Brigham has implemented a process to mitigate relevant financial relationships for this continuing education (CE) activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public. 

The following planners reported no relevant financial relationship with an ineligible company:
Saksham Gupta, MD
Lindsay Harris, NP
Jessica L Logsdon, PA-C, MHA
Colleen McGauley, NP
Ariel Nowicki, PA-C
Joseph Parseghian, PA-C
Patricia Riley, NP
Darlene Sawicki, NP
Erin Schroeder, NP
Michael Schontz, PharmD, BCPS, BCCCP


In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 CreditTM
Mass General Brigham designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity provides 1 contact hour (1 CEU) of continuing education credit. ACPE Universal Activity Number (UAN): JA0007437-0000-22-005-H04-P.

This offering carries 1.0 Pharmacotherapeutic contact hours

Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.


Please login or register to take this course.